|
EML4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.9857199999973E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.67850000004832E-06 |
| Normal-vs-Stage2 |
2.248200E-01 |
| Normal-vs-Stage3 |
8.364400E-03 |
| Normal-vs-Stage4 |
3.997000E-03 |
| Stage1-vs-Stage2 |
2.058000E-01 |
| Stage1-vs-Stage3 |
1.895430E-01 |
| Stage1-vs-Stage4 |
9.363600E-01 |
| Stage2-vs-Stage3 |
6.462400E-01 |
| Stage2-vs-Stage4 |
3.060000E-01 |
| Stage3-vs-Stage4 |
4.059800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.39589999999623E-05 |
| Normal-vs-AfricanAmerican |
6.541500E-03 |
| Normal-vs-Asian |
1.020060E-02 |
| Caucasian-vs-AfricanAmerican |
2.664200E-01 |
| Caucasian-vs-Asian |
8.650800E-01 |
| AfricanAmerican-vs-Asian |
2.952600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.805800E-04 |
| Normal-vs-Female |
3.99570000000349E-05 |
| Male-vs-Female |
9.965600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.53770000000231E-05 |
| Normal-vs-Age(41-60Yrs) |
2.972100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.466500E-02 |
| Normal-vs-Age(81-100Yrs) |
1.060030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.634400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.374600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.388400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.901400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.009000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.932800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.334400E-01 |
| Classical-VS-Follicular |
1.096470E-02 |
| Classical-VS-Other |
6.931800E-02 |
| Classical-VS-Normal |
1.50820000044405E-07 |
| Tall-VS-Follicular |
1.906620E-01 |
| Tall-VS-Other |
1.503760E-01 |
| Tall-VS-Normal |
1.163870E-02 |
| Follicular-VS-Other |
6.035000E-01 |
| Follicular-VS-Normal |
2.487800E-01 |
| Other-VS-Normal |
8.802600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.837200E-03 |
| Normal-vs-N1 |
1.476160E-02 |
| N0-vs-N1 |
9.563400E-01 |
|
|
